General Facts and Figures Classification Presentation History Physical Exam Labs Radiology Diagnosis Criteria for diagnosis Differential Microbiology General Specific organisms Pharmacology Drug Classes Mechanism of action Resistance Treatment General Site of care Medication Duration Assessment of responce Prevention References Literature cited Complete bibliography Links More...		Complete Bibliography Auble TE, Yealy DM, Fine MJ, Assessing prognosis and selecting an initial site of care for adults with community-acquired pneumonia, Infectious Disease Clinics of North America, 1998 Sep, 12(3):741-59. Baron S, ed., Medical Microbiology, 4th ed., 1998. Bartlett JG, Breiman RF, Mandell LA, File TM Jr., Community-acquired pneumonia in adults: guidelines for management, The Infectious Diseases Society of America, Clinical Infectious Diseases, 1998 Apr, 26(4):811-38. Bartlett JG, Mundy LM, Community-acquired pneumonia, The New England Journal of Medicine 1995 Dec 14, 333(24):1618-24. Campbell GD, Overview of community-acquired pneumonia: prognosis and clinical features, Medical Clinics of North America 1994, 78:1035-1048. Caputo GM, Applebaum PC, Liu HH, Infections due to penicillin-resistant pneumococci: clinical, epidemiologic and microbiologic features, Archives of Internal Medicine, 1993; 153:1301. Edelstein PH, Antimicrobial chemotherapy for Legionnaire's disease: a review, Clinical Infectious Diseases, 1995; 21(Suppl 3):S265-76. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections, European Respiratory Society, European Respiratory Journal, 1998 Apr, 11(4):986-91. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld, LA, et al, A prediction rule to identify low-risk patients with community-acquired pneumonia, NEJM, 1997 Jan 23, 336(4):243-50. Fine JM, Hough LJ, Medsger AR, Li YH, Ricci EM, et al, The hospital decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study, Archives of Internal Medicine, 1997 Jan 13, 157(1):36-44. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN, Prognosis and outcomes of patients with community-acquired pneumonia, a meta-analysis, JAMA 1996 Jan 10;275(2):134-41. Garibaldi RA, Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology and impact, Am Journal of Medicine, 1985; 78:32s-37s. Gilbert DN, Moellering RC Jr, Sande, MA, The Sanford Guide to Antimicrobial Therapy, 28th ed., Antimicrobial Therapy Inc., VA, 1998. Gonzales R, Steiner JF, Sande MA, Antibiotic prescribing for adults with colds, upper respiratory tract infections and bronchitis by ambulatory care physicians, JAMA 1997; 278:901-4. Graber MA, Toth PP, Herting RL Jr., University of Iowa Family Practice Handbook, www.vh.org/Providers/ClinRef/FPHandbook/FPContents.html, 3rd ed., Mosby, 1997. Guerra LG, Ho H, Verghese A, New pathogens in pneumonia, Medical Clinics of North America 1994, 78:967-985. Karetzky M, Burke AC, Brandstetter RD, The Pneumonias, Springer-Verlag, New York, 1993. Kauppinen M, Pekka S, Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment, Clinical Infectious Diseases, 1995;21:S244-52. Mandell LA, Antimicrobial approaches to therapy for pneumonia, Current Opinion in Pulmonary Medicine, 1996 May, 2(3):218-27. Mandell LA, Community-acquired pneumonia: etiology, epidemiology, and treatment, Chest 1995, 108:35S-42S. Mandell LA, Antibiotics for pneumonia therapy, Medical Clinics of North America 1994, 78:997-1014. Marrie TJ, New aspects of old pathogens of pneumonia, Medical Clinics of North America 1994, 78:987-995. Marrie TJ, Community-acquired pneumonia: epidemiology, etiology, treatment, Infectious Disease Clinics of North America, 1998 Sep, 12(3):723-40. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA, Medical Microbiology, 3rd ed., Mosby, 1998. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F, Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain, N Engl J Med 1995 Aug 24;333(8):474-80 (Published erratum appears in N Engl J Med 1995 Dec 14;333(24):1655). Plouffe JF, McNally C, File TM Jr., Value of noninvasive studies in community-acquired pneumonia, Infectious Disease Clinics of North America, 1998 Sep, 12(3):689-99. Pomilla PV, Brown RB, Outpatient treatment of community-acquired pneumonia in adults, Archives of Internal Medicine, 1994 Aug; 154:1793-1802. Skerret SJ, Host defenses against respiratory infection, Medical Clinics of North America 1994, 78:941-966. Sopena N, Sabria-Leal M, Pedro-Botet ML, Padilla E, Dominguez J, Morera J, Tudela P, Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias, Chest 1998 May;113(5):1195-200. Volk WA, Gebhardt BM, Hammarskj–ld M, Kadner RJ, Essentials of Medical Microbiology, 5th ed., Lippincott-Raven, Philadelphia, 1996.

medschool.ucsd.edu/curricular_resources/MED/CAP/index.html   4/1/99